To determine whether intranasal delivery of 9-cis RA affects amyloid pathology, we treated 6-month-old APP/PS1 mice for a period of 4 weeks, as these mice are known to develop amyloid plaques at 5 to 6 months [16]. The gene discussed is APP; the disease is amyloidosis.